Progestins: all 372 studies that test it

Page 4 of 4. Open to participants first (45), then studies with results posted, then the rest; newest registration first within each.

• Uterine Electrical Activity Before and After Progesterone Treatment for Preterm LaborWithdrawnNCT01406197Not applicable
• New Treatments for Troublesome Bleeding in Implanon UsersStatus unknownNCT01384331Phase 4
• Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With ProgesteroneStatus unknownNCT01317225Phase 3
• Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres SuspensionCompletedNCT01293747Phase 1
• A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral ContraceptivesCompletedNCT01291004Phase 1
• Randomized Controlled Trial of Vaginal Progesterone in Women With Threatened Preterm LaborTerminatedNCT01286246Phase 4
• Progesterone and Second Trimester BleedingTerminatedNCT01269450Not applicable
• Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's HealthStatus unknownNCT01256619Phase 2
• Assessment of Desogestrel in Ondine SyndromeCompletedNCT01243697Phase 2/3
• Vaginal Progesterone as a Treatment for Women Active Preterm LaborWithdrawnNCT01206998Not applicable
• Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.CompletedNCT01204190Phase 2
• Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase SupportCompletedNCT01178931Not applicable
• Progestagens for the Tertiary Prophylaxis of Preterm DeliveryCompletedNCT01178788Phase 3
• Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) StudyCompletedNCT01176175Phase 1
• Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of MenacmeCompletedNCT01174524Phase 4
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine LeiomyomataCompletedNCT01156857Phase 3
• Prolongation of Progesterone Supplementation in Antagonist Cycles and Pregnancy OutcomesCompletedNCT01147770Phase 1/2
• Progesterone vs Clobetasol Propionate in Vulvar Lichen SclerosusTerminatedNCT01126255Phase 2
• Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression ProfileStatus unknownNCT01123538Phase 4
• Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications SitesCompletedNCT01083264Phase 1
• A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)CompletedNCT01081652Phase 3
• Compare the Difference of P4 Concentration in Serum and Endometrium After Vaginal and IM P AdministrationCompletedNCT01057511Phase 1/2
• Luteal Support and Intrauterine Insemination (IUI) With Clomiphene CitrateCompletedNCT01046708Not applicable
• Prophylactic Administration of Natural Progesterone in the Prevention of Preterm Delivery in Twin PregnanciesCompletedNCT01031017Phase 4
• Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary CalculusStatus unknownNCT01010048Phase 4
• Birth Control Patch StudyCompletedNCT00984789Phase 3
• FC Patch Low: Metabolism StudyCompletedNCT00933179Phase 2
• PP13 and Doppler Study to Predict PreeclampsiaStatus unknownNCT00928213Phase 2/3
• US Cycle Control and Blood Pressure StudyCompletedNCT00920985Phase 3
• Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by EstrogenStatus unknownNCT00919919Phase 2
• Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)CompletedNCT00915915Phase 2
• EU/LA Pearl Index Study - Transdermal Contraceptive PatchCompletedNCT00914693Phase 3
• Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 CyclesCompletedNCT00910637Phase 3
• US Ovulation Inhibition Study in Obese WomenCompletedNCT00873483Phase 2
• Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)Status unknownNCT00873262Phase 2
• Evaluation of Efficacy/Safety of EVE-PMS Skin Test PanelStatus unknownNCT00866437Phase 2
• Natural Versus HRT Cycles in Frozen Embryo Replacement TreatmentCompletedNCT00843570Phase 4
• 17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm LaborStatus unknownNCT00809939Phase 3
• Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.CompletedNCT00775242Phase 2/3
• Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal WomenCompletedNCT00755963Phase 4
• Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian FailureCompletedNCT00732693Phase 4
• Inhibition of Ovulation, Patch, Ethinylestradiol and GestodeneTerminatedNCT00729404Phase 2
• A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.Status unknownNCT00708539Phase 4
• Does Hormonal Luteal Support After Intra-uterine Insemination (IUI) Increase the Pregnancy Rate?TerminatedNCT00700492Not applicable
• Vaginal PROgesterone as Maintenance Treatment After an epISode of prEterm Labor (PROMISE Study)CompletedNCT00646802Phase 4
• Sex Differences in Progesterone Effects on Responses to Stress and Drug CuesCompletedNCT00585520Phase 1
• Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in WomenCompletedNCT00565240Not applicable
• Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm LaborTerminatedNCT00536003Phase 3
• Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal WomenCompletedNCT00530582Phase 4
• Natural Progesterone and Preterm Birth in TwinsCompletedNCT00480402Phase 3
• Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled TrialCompletedNCT00422526Phase 3
• Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference FormulationCompletedNCT00401219Phase 1
• Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy VolunteersCompletedNCT00377923Phase 1
• Vaginal Progesterone Versus Placebo in Multiple PregnancyCompletedNCT00343265Not applicable
• Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?CompletedNCT00329914Phase 2
• Prevention of Recurrent Preterm Delivery by a Natural Progesterone AgentWithdrawnNCT00329316Not applicable
• Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)CompletedNCT00296478Phase 3
• Effect of Progesterone on Smoking Behavior in Male and Female SmokersCompletedNCT00271206Phase 1
• Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and IICompletedNCT00247169Phase 2
• Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?CompletedNCT00206544Phase 2
• Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual CycleCompletedNCT00204438Not applicable
• A Trial to Evaluate DR-2021 in Women With Secondary AmenorrheaCompletedNCT00196391Phase 2
• Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent MiscarriageCompletedNCT00193674Phase 3
• A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring ContraceptionCompletedNCT00185419Phase 3
• Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone CombinationCompletedNCT00160316Phase 3
• Kronos Early Estrogen Prevention Study (KEEPS)Status unknownNCT00154180Phase 4
• Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized ProgesteroneStatus unknownNCT00152438Phase 2
• Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone CaproateCompletedNCT00141908Phase 2
• Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)CompletedNCT00099164Phase 3
• Vaginal Progesterone to Reduce the Risk of Another Preterm BirthCompletedNCT00086177Phase 3
• Progesterone Treatment of Blunt Traumatic Brain InjuryCompletedNCT00048646Phase 1/2
• Progesterone Treatment in Female Smokers - 12CompletedNCT00000295Phase 2

← Progestins overview